Hanover Bancorp vs Orange County Bancorp
HNVR and OBT side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HNVR and OBT compare
Orange County Bancorp is the larger company, worth 3.4 times as much as Hanover Bancorp ($537M against $158M).
On earnings, Orange County Bancorp is cheaper: it trades at 10.7× trailing earnings, against 15.8× for Hanover Bancorp.
Orange County Bancorp keeps more of each dollar of sales as profit, with a net margin of 38.9% compared with 13.5% at Hanover Bancorp.
Both pay dividends: Hanover Bancorp yields 1.8% and Orange County Bancorp 1.8%.
Orange County Bancorp scores higher on the StockData Score (19 against 11 for Hanover Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HNVR | OBT |
|---|---|---|
| Size and price | ||
| Market cap | $158M | $537M |
| Share price | $22.33 | $40.03 |
| Change, 1 year | 0.95% | 53.6% |
| Change, 5 years | – | 112% |
| Beta (5Y) | 0.29 | 0.36 |
| Employees | 194 | 33 |
| StockData Score | ||
| Total score | 11 | 19 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 6 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 15.8× | 10.7× (better) |
| P/S | 2.1× (better) | 4.2× |
| P/B | 0.8× (better) | 1.7× |
| P/FCF | 4.1× (better) | 8.7× |
| PEG | – | 0.70 |
| FCF yield | 24.1% (better) | 11.5% |
| Fair value | $22.73 | $36.77 |
| Margin of safety | 1.8% (better) | −8.9% |
| Growth | ||
| Revenue growth (TTM) | – | 5.5% |
| Revenue growth, 5Y average | – | 16.2% |
| Net income growth (TTM) | – | 37.2% |
| EPS growth (TTM) | – | 23.5% |
| EPS growth, 5Y average | – | 20.8% |
| Profitability | ||
| Net margin | 13.5% | 38.9% (better) |
| FCF margin | 49.7% (better) | 48.0% |
| Return on equity | 5.1% | 17.2% (better) |
| Financial health | ||
| Debt / equity | 0.29 | – |
| Altman Z-score | 0.12 | 0.28 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.8% | 1.8% (better) |
| Payout ratio | 28.9% | 19.3% |
| Years of dividend growth | 0 | 4 (better) |
| Dividend growth, 5Y average | – | 7.3% |
| Shareholder yield | 1.8% | 1.8% (better) |
| Ownership | ||
| Held by institutions | 25.8% | 54.0% |
| Held by insiders | 25.9% | 8.5% |
| Insider net buying, 12 months | −$253K (better) | −$276K |
| Short interest, % of float | 0.80% | 0.87% |
Go deeper
- HNVR stock overview
- HNVR income statement
- HNVR valuation and score
- OBT stock overview
- OBT income statement
- OBT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.